About Innova Captab Limited
Data last updated: 02 July 2026
Innova Captab Limited is a public limited company based in Thane, Maharashtra, India. It specialises in chemical products, a part of the broader chemicals sector. Incorporated on 03 January 2005, the company has been in operation for over 21 years.
Registered with ROC Mumbai under CIN L24246MH2005PLC150371. Listed.
Capital: an authorised share capital of ₹66 Cr and a paid-up capital of ₹57.22 Cr. Formerly known as Innova Captab Private Limited and Harun Health Care Private Limited. It is led by directors including Jayant Vasudeo Rao and Shirish Gundopant Belapure.
Last AGM: 31 July 2025. Financial statements filed for year ended 31 March 2025. Office: Thane, Maharashtra.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹1,630.02 Cr, a growth of 31.06% compared to the previous year. The net worth stands at ₹1,090.79 Cr (up 13.69% YoY). Total assets are valued at ₹1,837.38 Cr (up 16.26% YoY).
The company has a workforce of approximately 1,246 employees as per the latest available data. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand - Innova Captab. As per MCA filings, the company has open charges of ₹505.32 Cr and satisfied charges of ₹158.4 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innovacaptab.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address1513 15Th Floor Satra Plaza Chs Ltd., Plot No. 19 & 20 Sector – 19D Vashi Navi Mumbai, Thane, Maharashtra, India – 400703
-
IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Innova Captab Limited
Innova Captab Limited has undergone 2 name changes throughout its history. The company was previously known as Innova Captab Private Limited, and Harun Health Care Private Limited. The current legal name is Innova Captab Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Innova Captab Limited | Current |
| Innova Captab Private Limited | Previous |
| Harun Health Care Private Limited | Previous |
CIN History of Innova Captab Limited
Innova Captab Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24246MH2005PLC150371, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24246MH2005PLC150371 | Current |
| U24246MH2005PTC150371 | Previous |
| U24246MH2005PLC150371 | Previous |
Associated Brands with Innova Captab Limited
Innova Captab Limited operates one associated brand: Innova Captab. These brands represent Innova Captab Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations are manufactured by Innova Captab as a CDMO. | innovacaptab.com |
Competitors & Alternatives of Innova Captab Limited
Brands and companies operating in the same space as Innova Captab Limited include Pharmaron, Pfizer, Lonza and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Pharmaron
|
Drug discovery and development services for small molecules are provided. | Beijing, China, China | 2003 |
Pfizer
|
Pharmaceutical products for treating multiple diseases are provided. | New York, United States, United States | 1849 |
Lonza
|
CDMO services for pharma, biotech, and specialty ingredients are provided. | Basel, Switzerland, Switzerland | 1897 |
Dotmatics
|
AI powered scientific data management and workflow automation solutions | - | 2005 |
Boehringer Ingelheim
|
Generic drugs and clinical research services are provided globally. | - | 1885 |
LabConnect
|
Laboratory testing, clinical trial research, and biopharma services are provided. | Johnson City, United States, United States | 2002 |
Beta Drugs
|
Developer of therapeutics for oncology and dermatology | Panchkula, India, India | 2005 |
Ainos
|
Novel point-of-care testing and low-dose interferon therapeutics are developed. | San Diego, United States, United States | 1986 |
Biomatter
|
Provider of synthetic biology and AI-based technology for generative protein design | Vilnius, Lithuania, Lithuania | 2018 |
Business Activity of Innova Captab Limited
Innova Captab Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Innova Captab Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Innova Captab Limited
Innova Captab Limited is audited by B S R & Co. LLP (ICAI peer reviewed, certificate valid till 2028-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| B S R & Co. LLP (ICAI peer reviewed, certificate valid till 2028-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Innova Captab Limited
Innova Captab Limited is currently managed by 8 directors, with 18 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Jayant Vasudeo Rao
Also directs:
Innova Captab Limited, Sharon Bio-Medicine Limited
|
Whole-Time Director | 22 Nov 2017 | 8 Years 8 Months | Current |
|
Shirish Gundopant Belapure
Also directs:
Innova Captab Limited, Bellapure Onco Phytoceuticals Llp, Jubilant Pharmova Limited and 4 more
|
Director | 01 Apr 2022 | 4 Years 4 Months | Current |
|
Sudhir Kumar Bassi
Also directs:
Innova Captab Limited, Saatvik Green Energy Limited
|
Director | 01 Apr 2022 | 4 Years 4 Months | Current |
| Priyanka Dixit | Director | 01 Apr 2022 | 4 Years 4 Months | Current |
|
Archit Aggarwal
Also directs:
Innova Captab Limited, Innoventis Medicare Limited, Archit Infrastructure And Developers Llp and 5 more
|
Director | 01 Apr 2022 | 4 Years 4 Months | Current |
| Manoj Kumar Lohariwala | Whole-Time Director | 03 Jun 2009 | 17 Years 2 Months | Current |
Financials of Innova Captab Limited FY 2026 filings available
Innova Captab Limited reported revenue of ₹1,630.02 Cr (up 31.06% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Revenue from Operations | ₹1,630.02 Cr | ₹1,243.68 Cr | ₹1,081.31 Cr |
| Other Income | ₹7.42 Cr | ₹12.05 Cr | ₹12.49 Cr |
| Total Income | ₹1,637.44 Cr | ₹1,255.72 Cr | ₹1,093.79 Cr |
| Cost of Materials Consumed | ₹1,005.46 Cr | ₹799.82 Cr | ₹696.12 Cr |
| Purchases of Stock-in-Trade | ₹58.33 Cr | ₹39.22 Cr | ₹35.54 Cr |
| Changes in Inventories | -₹11 Cr | -₹24.94 Cr | -₹3.32 Cr |
| Employee Benefit Expense | ₹167.2 Cr | ₹116.78 Cr | ₹90.66 Cr |
| Finance Costs | ₹16.9 Cr | ₹2.41 Cr | ₹21.46 Cr |
| Depreciation & Amortisation | ₹45.18 Cr | ₹24.78 Cr | ₹15.96 Cr |
| Other Expenses | ₹167.1 Cr | ₹126.65 Cr | ₹107.85 Cr |
| Total Expenses | ₹1,449.17 Cr | ₹1,084.71 Cr | ₹964.26 Cr |
| Profit Before Exceptional Items & Tax | ₹188.26 Cr | ₹171.02 Cr | ₹129.53 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹188.26 Cr | ₹171.02 Cr | ₹129.53 Cr |
| Total Tax Expense | ₹47.35 Cr | ₹42.76 Cr | ₹35.18 Cr |
| Net Profit | ₹140.92 Cr | ₹128.26 Cr | ₹94.35 Cr |
| attributable to Owners | ₹0 | ₹0 | ₹0 |
| attributable to NCI | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹40.6 Lakh | ₹26.5 Lakh | ₹1.89 Cr |
| Total Comprehensive Income | ₹141.32 Cr | ₹128.52 Cr | ₹96.23 Cr |
| EBITDA (computed) | ₹250.34 Cr | ₹198.2 Cr | ₹166.94 Cr |
| Basic EPS | ₹24.63 | ₹22.41 | ₹18.66 |
| Diluted EPS | ₹24.63 | ₹22.41 | ₹18.66 |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Total Assets | ₹1,837.38 Cr | ₹1,580.41 Cr | ₹1,320.88 Cr |
| Non-current Assets | ₹914.42 Cr | ₹877.29 Cr | ₹741.13 Cr |
| Current Assets | ₹922.96 Cr | ₹695.69 Cr | ₹579.75 Cr |
| Property, Plant & Equipment | ₹823.33 Cr | ₹812.43 Cr | ₹340.29 Cr |
| Inventories | ₹283.26 Cr | ₹208 Cr | ₹144.02 Cr |
| Trade Receivables | ₹437.29 Cr | ₹331.65 Cr | ₹288.49 Cr |
| Cash & Equivalents | ₹3.2 Cr | ₹15.52 Cr | ₹11.73 Cr |
| Equity (Net Worth) | ₹1,090.79 Cr | ₹959.42 Cr | ₹830.89 Cr |
| Equity Share Capital | ₹57.23 Cr | ₹57.23 Cr | ₹57.23 Cr |
| Borrowings (Non-current) | ₹215.82 Cr | ₹244.89 Cr | ₹210.52 Cr |
| Borrowings (Current) | ₹127.87 Cr | ₹93.23 Cr | ₹34.58 Cr |
| Total Debt (computed) | ₹343.69 Cr | ₹338.12 Cr | ₹245.1 Cr |
| Current Liabilities | ₹494.58 Cr | ₹353 Cr | ₹265.48 Cr |
| Total Liabilities | ₹746.59 Cr | ₹620.99 Cr | ₹489.99 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Operating Cash Flow | ₹116.52 Cr | ₹63.84 Cr | ₹146.34 Cr |
| Investing Cash Flow | -₹107.12 Cr | -₹151.59 Cr | -₹498.97 Cr |
| Financing Cash Flow | -₹21.72 Cr | ₹91.53 Cr | ₹360.83 Cr |
| Capital Expenditure | ₹68.35 Cr | ₹172.5 Cr | ₹287.35 Cr |
| Free Cash Flow (computed) | ₹48.16 Cr | -₹108.65 Cr | -₹141.01 Cr |
| Dividends Paid | ₹11.44 Cr | ₹0 | ₹0 |
| Net Change in Cash | -₹12.32 Cr | ₹3.79 Cr | ₹8.2 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹447.8 Cr | ₹450.29 Cr | ₹380.38 Cr | ₹351.54 Cr | ₹314.74 Cr | ₹316.46 Cr | ₹318.2 Cr | ₹294.27 Cr | ₹262.63 Cr | ₹302.49 Cr | ₹282.94 Cr |
| Other Income | ₹1.56 Cr | ₹1.65 Cr | ₹4.19 Cr | ₹4.48 Cr | ₹3.38 Cr | ₹4.33 Cr | ₹2.22 Cr | ₹2.12 Cr | ₹5.68 Cr | ₹2.34 Cr | ₹3.34 Cr |
| Total Income | ₹449.37 Cr | ₹451.95 Cr | ₹384.57 Cr | ₹356.03 Cr | ₹318.12 Cr | ₹320.79 Cr | ₹320.42 Cr | ₹296.39 Cr | ₹268.32 Cr | ₹304.83 Cr | ₹286.28 Cr |
| Cost of Materials Consumed | ₹261.24 Cr | ₹280.84 Cr | ₹233.95 Cr | ₹229.44 Cr | ₹210.93 Cr | ₹195.76 Cr | ₹205.02 Cr | ₹188.12 Cr | ₹160.05 Cr | ₹190.94 Cr | ₹178.73 Cr |
| Purchases of Stock-in-Trade | ₹32.58 Cr | ₹15.06 Cr | ₹5.65 Cr | ₹5.05 Cr | ₹5.3 Cr | ₹11.18 Cr | ₹14.27 Cr | ₹8.47 Cr | ₹12.02 Cr | ₹6 Cr | ₹9.38 Cr |
| Changes in Inventories | ₹2.84 Cr | -₹4.08 Cr | ₹3.99 Cr | -₹13.75 Cr | -₹18.2 Cr | ₹2.98 Cr | -₹12.31 Cr | ₹2.58 Cr | -₹3.81 Cr | ₹5.14 Cr | ₹3.35 Cr |
| Employee Benefit Expense | ₹42.62 Cr | ₹43.78 Cr | ₹41.72 Cr | ₹39.09 Cr | ₹35.52 Cr | ₹28.21 Cr | ₹28.17 Cr | ₹24.88 Cr | ₹25.9 Cr | ₹25.63 Cr | ₹24.25 Cr |
| Finance Costs | ₹4.59 Cr | ₹3.95 Cr | ₹5.5 Cr | ₹2.86 Cr | ₹1.95 Cr | ₹16.6 Lakh | ₹14.9 Lakh | ₹13.8 Lakh | ₹81.3 Lakh | ₹6.8 Cr | ₹8.81 Cr |
| Depreciation & Amortisation | ₹11.39 Cr | ₹11.42 Cr | ₹11.32 Cr | ₹11.05 Cr | ₹9.8 Cr | ₹5.13 Cr | ₹4.99 Cr | ₹4.85 Cr | ₹3.41 Cr | ₹4.93 Cr | ₹4.83 Cr |
| Other Expenses | ₹43.44 Cr | ₹45.3 Cr | ₹43.22 Cr | ₹39.62 Cr | ₹33.52 Cr | ₹31.76 Cr | ₹33.31 Cr | ₹28.05 Cr | ₹30.39 Cr | ₹30.18 Cr | ₹26.76 Cr |
| Total Expenses | ₹398.69 Cr | ₹396.27 Cr | ₹345.34 Cr | ₹313.35 Cr | ₹278.81 Cr | ₹275.2 Cr | ₹273.61 Cr | ₹257.09 Cr | ₹228.77 Cr | ₹269.62 Cr | ₹256.1 Cr |
| Profit Before Exceptional Items & Tax | ₹50.68 Cr | ₹55.68 Cr | ₹39.24 Cr | ₹42.68 Cr | ₹39.31 Cr | ₹45.59 Cr | ₹46.81 Cr | ₹39.31 Cr | ₹39.55 Cr | ₹35.2 Cr | ₹30.18 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹50.68 Cr | ₹55.68 Cr | ₹39.24 Cr | ₹42.68 Cr | ₹39.31 Cr | ₹45.59 Cr | ₹46.81 Cr | ₹39.31 Cr | ₹39.55 Cr | ₹35.2 Cr | ₹30.18 Cr |
| Total Tax Expense | ₹12.59 Cr | ₹13.53 Cr | ₹9.57 Cr | ₹11.66 Cr | ₹9.74 Cr | ₹11.38 Cr | ₹11.81 Cr | ₹9.83 Cr | ₹10.82 Cr | ₹10.07 Cr | ₹7.28 Cr |
| Net Profit | ₹38.08 Cr | ₹42.15 Cr | ₹29.67 Cr | ₹31.02 Cr | ₹29.57 Cr | ₹34.2 Cr | ₹35 Cr | ₹29.48 Cr | ₹28.72 Cr | ₹25.13 Cr | ₹22.91 Cr |
| attributable to Owners | ₹0 | ₹0 | - | - | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 |
| attributable to NCI | ₹0 | ₹0 | - | - | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹24.4 Lakh | ₹61.9 Lakh | -₹46.1 Lakh | ₹40,000 | ₹37.2 Lakh | -₹3 Lakh | ₹1.6 Lakh | -₹9.3 Lakh | ₹1.55 Cr | ₹70,000 | ₹11.7 Lakh |
| Total Comprehensive Income | ₹38.33 Cr | ₹42.77 Cr | ₹29.21 Cr | ₹31.02 Cr | ₹29.95 Cr | ₹34.17 Cr | ₹35.02 Cr | ₹29.38 Cr | ₹30.27 Cr | ₹25.13 Cr | ₹23.02 Cr |
| EBITDA (computed) | ₹66.66 Cr | ₹71.05 Cr | ₹56.05 Cr | ₹56.58 Cr | ₹51.07 Cr | ₹50.89 Cr | ₹51.95 Cr | ₹44.3 Cr | ₹43.76 Cr | ₹46.94 Cr | ₹43.82 Cr |
| Basic EPS | ₹6.65 | ₹7.37 | ₹5.18 | ₹5.42 | ₹5.17 | ₹5.97 | ₹6.12 | ₹5.15 | ₹5.02 | ₹4.39 | ₹4.77 |
| Diluted EPS | ₹6.65 | ₹7.37 | ₹5.18 | ₹5.42 | ₹5.17 | ₹5.97 | ₹6.12 | ₹5.15 | ₹5.02 | ₹4.39 | ₹4.77 |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Revenue from Operations | ₹1,298.81 Cr | ₹958.06 Cr | ₹864.93 Cr |
| Other Income | ₹13.24 Cr | ₹16.78 Cr | ₹10.72 Cr |
| Total Income | ₹1,312.06 Cr | ₹974.84 Cr | ₹875.65 Cr |
| Cost of Materials Consumed | ₹901.37 Cr | ₹715.51 Cr | ₹640.47 Cr |
| Purchases of Stock-in-Trade | ₹37.84 Cr | ₹68.4 Lakh | ₹6.4 Cr |
| Changes in Inventories | -₹2.28 Cr | -₹11.34 Cr | -₹1.35 Cr |
| Employee Benefit Expense | ₹111.09 Cr | ₹62.74 Cr | ₹50.11 Cr |
| Finance Costs | ₹15.42 Cr | ₹2.17 Cr | ₹13.59 Cr |
| Depreciation & Amortisation | ₹37.37 Cr | ₹17.02 Cr | ₹11.4 Cr |
| Other Expenses | ₹99.42 Cr | ₹68.17 Cr | ₹61.33 Cr |
| Total Expenses | ₹1,200.24 Cr | ₹854.95 Cr | ₹781.95 Cr |
| Profit Before Exceptional Items & Tax | ₹111.82 Cr | ₹119.89 Cr | ₹93.7 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹111.82 Cr | ₹119.89 Cr | ₹93.7 Cr |
| Total Tax Expense | ₹28.13 Cr | ₹30.42 Cr | ₹25.54 Cr |
| Net Profit | ₹83.69 Cr | ₹89.47 Cr | ₹68.16 Cr |
| Other Comprehensive Income | -₹5.5 Lakh | -₹22.2 Lakh | ₹27.7 Lakh |
| Total Comprehensive Income | ₹83.64 Cr | ₹89.25 Cr | ₹68.44 Cr |
| EBITDA (computed) | ₹164.61 Cr | ₹139.07 Cr | ₹118.69 Cr |
| Basic EPS | ₹14.63 | ₹15.63 | ₹13.48 |
| Diluted EPS | ₹14.63 | ₹15.63 | ₹13.48 |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Total Assets | ₹1,547.09 Cr | ₹1,365.14 Cr | ₹1,155.07 Cr |
| Non-current Assets | ₹797.26 Cr | ₹836.04 Cr | ₹717.63 Cr |
| Current Assets | ₹749.83 Cr | ₹529.11 Cr | ₹437.44 Cr |
| Property, Plant & Equipment | ₹646.78 Cr | ₹636.91 Cr | ₹162.84 Cr |
| Inventories | ₹204.21 Cr | ₹139.95 Cr | ₹93.99 Cr |
| Trade Receivables | ₹330.19 Cr | ₹248.9 Cr | ₹217.39 Cr |
| Cash & Equivalents | ₹1.37 Cr | ₹15.31 Cr | ₹11.39 Cr |
| Equity (Net Worth) | ₹886.65 Cr | ₹812.97 Cr | ₹723.72 Cr |
| Equity Share Capital | ₹57.23 Cr | ₹57.23 Cr | ₹57.23 Cr |
| Borrowings (Non-current) | ₹215.82 Cr | ₹244.89 Cr | ₹208.2 Cr |
| Borrowings (Current) | ₹105.47 Cr | ₹84.28 Cr | ₹32.59 Cr |
| Total Debt (computed) | ₹321.3 Cr | ₹329.18 Cr | ₹240.79 Cr |
| Current Liabilities | ₹414.25 Cr | ₹290.16 Cr | ₹213.4 Cr |
| Total Liabilities | ₹660.43 Cr | ₹552.18 Cr | ₹431.35 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Operating Cash Flow | ₹34.11 Cr | ₹19.8 Cr | ₹111.67 Cr |
| Investing Cash Flow | -₹14.06 Cr | -₹99.75 Cr | -₹471.55 Cr |
| Financing Cash Flow | -₹33.99 Cr | ₹83.86 Cr | ₹368.13 Cr |
| Capital Expenditure | ₹61.79 Cr | ₹160.93 Cr | ₹277.23 Cr |
| Free Cash Flow (computed) | -₹27.69 Cr | -₹141.13 Cr | -₹165.56 Cr |
| Dividends Paid | ₹11.44 Cr | ₹0 | ₹0 |
| Net Change in Cash | -₹13.94 Cr | ₹3.92 Cr | ₹8.25 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹358.28 Cr | ₹363.73 Cr | ₹289.83 Cr | ₹286.98 Cr | ₹242.52 Cr | ₹248.53 Cr | ₹240.18 Cr | ₹226.83 Cr | ₹198.1 Cr | ₹236.46 Cr | ₹211.73 Cr |
| Other Income | ₹2.68 Cr | ₹3.21 Cr | ₹4.63 Cr | ₹4.32 Cr | ₹4.36 Cr | ₹3.49 Cr | ₹4.28 Cr | ₹4.64 Cr | ₹6.01 Cr | ₹1.77 Cr | ₹2.11 Cr |
| Total Income | ₹360.96 Cr | ₹366.93 Cr | ₹294.46 Cr | ₹291.29 Cr | ₹246.88 Cr | ₹252.02 Cr | ₹244.46 Cr | ₹231.48 Cr | ₹204.11 Cr | ₹238.23 Cr | ₹213.84 Cr |
| Cost of Materials Consumed | ₹236.33 Cr | ₹256.49 Cr | ₹205.1 Cr | ₹203.46 Cr | ₹187.42 Cr | ₹175.12 Cr | ₹183.11 Cr | ₹169.87 Cr | ₹145.1 Cr | ₹171.47 Cr | ₹157.49 Cr |
| Purchases of Stock-in-Trade | ₹27.51 Cr | ₹8.65 Cr | ₹40.6 Lakh | ₹1.28 Cr | ₹23.4 Lakh | ₹13.3 Lakh | ₹17.9 Lakh | ₹13.8 Lakh | ₹4.98 Cr | ₹14.8 Lakh | ₹1.25 Cr |
| Changes in Inventories | ₹29.2 Lakh | -₹4.59 Cr | ₹3.1 Cr | -₹1.08 Cr | -₹13.61 Cr | ₹7.95 Cr | -₹8.46 Cr | ₹2.78 Cr | -₹4.92 Cr | ₹5.28 Cr | ₹1.37 Cr |
| Employee Benefit Expense | ₹28.2 Cr | ₹30.05 Cr | ₹27.5 Cr | ₹25.35 Cr | ₹21.32 Cr | ₹14.75 Cr | ₹14.72 Cr | ₹11.96 Cr | ₹13.11 Cr | ₹13.3 Cr | ₹12.13 Cr |
| Finance Costs | ₹3.98 Cr | ₹3.47 Cr | ₹5.21 Cr | ₹2.77 Cr | ₹1.87 Cr | ₹13.3 Lakh | ₹7.7 Lakh | ₹8.9 Lakh | ₹12 Lakh | ₹3.81 Cr | ₹5.2 Cr |
| Depreciation & Amortisation | ₹9.4 Cr | ₹9.41 Cr | ₹9.48 Cr | ₹9.08 Cr | ₹7.81 Cr | ₹3.08 Cr | ₹3.07 Cr | ₹3.06 Cr | ₹2.93 Cr | ₹2.97 Cr | ₹2.81 Cr |
| Other Expenses | ₹27.32 Cr | ₹26.15 Cr | ₹24.4 Cr | ₹23.15 Cr | ₹18.98 Cr | ₹18.09 Cr | ₹17.46 Cr | ₹13.64 Cr | ₹16.44 Cr | ₹15.74 Cr | ₹13.21 Cr |
| Total Expenses | ₹333.02 Cr | ₹329.61 Cr | ₹275.19 Cr | ₹264 Cr | ₹224.02 Cr | ₹219.25 Cr | ₹210.15 Cr | ₹201.53 Cr | ₹177.76 Cr | ₹212.72 Cr | ₹193.46 Cr |
| Profit Before Exceptional Items & Tax | ₹27.94 Cr | ₹37.33 Cr | ₹19.27 Cr | ₹27.29 Cr | ₹22.86 Cr | ₹32.77 Cr | ₹34.32 Cr | ₹29.95 Cr | ₹26.35 Cr | ₹25.51 Cr | ₹20.38 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹27.94 Cr | ₹37.33 Cr | ₹19.27 Cr | ₹27.29 Cr | ₹22.86 Cr | ₹32.77 Cr | ₹34.32 Cr | ₹29.95 Cr | ₹26.35 Cr | ₹25.51 Cr | ₹20.38 Cr |
| Total Tax Expense | ₹6.77 Cr | ₹9.43 Cr | ₹4.94 Cr | ₹7 Cr | ₹5.73 Cr | ₹8.37 Cr | ₹8.71 Cr | ₹7.61 Cr | ₹6.63 Cr | ₹6.86 Cr | ₹5.91 Cr |
| Net Profit | ₹21.16 Cr | ₹27.9 Cr | ₹14.33 Cr | ₹20.3 Cr | ₹17.13 Cr | ₹24.4 Cr | ₹25.61 Cr | ₹22.34 Cr | ₹19.72 Cr | ₹18.65 Cr | ₹14.47 Cr |
| Other Comprehensive Income | ₹34.1 Lakh | ₹80,000 | -₹13.2 Lakh | -₹27.2 Lakh | ₹5.8 Lakh | -₹12.5 Lakh | -₹8.1 Lakh | -₹7.4 Lakh | -₹4.1 Lakh | ₹3.6 Lakh | ₹70,000 |
| Total Comprehensive Income | ₹21.5 Cr | ₹27.91 Cr | ₹14.2 Cr | ₹20.02 Cr | ₹17.18 Cr | ₹24.28 Cr | ₹25.53 Cr | ₹22.26 Cr | ₹19.68 Cr | ₹18.69 Cr | ₹14.48 Cr |
| EBITDA (computed) | ₹41.32 Cr | ₹50.2 Cr | ₹33.96 Cr | ₹39.14 Cr | ₹32.54 Cr | ₹35.99 Cr | ₹37.46 Cr | ₹33.09 Cr | ₹29.4 Cr | ₹32.29 Cr | ₹28.39 Cr |
| Basic EPS | ₹3.70 | ₹4.88 | ₹2.50 | ₹3.55 | ₹2.99 | ₹4.26 | ₹4.48 | ₹3.90 | ₹3.45 | ₹3.26 | ₹3.02 |
| Diluted EPS | ₹3.70 | ₹4.88 | ₹2.50 | ₹3.55 | ₹2.99 | ₹4.26 | ₹4.48 | ₹3.90 | ₹3.45 | ₹3.26 | ₹3.02 |
Shareholding Pattern of Innova Captab Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 50.90%, foreign institutional investors hold 0.23%, domestic institutional investors hold 20.14%, retail and other public shareholders hold 28.73% of Innova Captab Limited. The company had 36,965 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% |
| Public | 49.10% | 49.10% | 49.10% | 49.10% | 49.10% | 49.10% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 50.90% | 50.90% | 50.90% |
| Public | 49.10% | 49.10% | 49.10% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | - |
Board & Governance of Innova Captab Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Innova Captab Limited has 8 directors - 4 independent and 3 executive. The board is chaired by Manoj Kumar Lohariwala.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Manoj Kumar Lohariwala | Executive Director · Chairperson | 2009-06-03 | 1 |
| Vinay Lohariwala | Executive Director · MD | 2010-03-03 | 1 |
| Jayant Vasudeo Rao | Executive Director | 2017-11-22 | 1 |
| Archit Aggarwal | Non-Executive - Non Independent Director | 2022-04-01 | 1 |
| Sudhir Kumar Bassi | Non-Executive - Independent Director | 2022-04-01 | 2 |
| Shirish Gundopant Belapure | Non-Executive - Independent Director | 2022-04-01 | 4 |
| Mahendar Korthiwada | Non-Executive - Independent Director | 2022-04-01 | 1 |
| Priyanka Dixit | Non-Executive - Independent Director | 2022-04-01 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Sudhir Kumar Bassi (Chairperson), Vinay Lohariwala, Shirish Gundopant Belapure, Mahendar Korthiwada |
| Nomination and remuneration committee | Sudhir Kumar Bassi (Chairperson), Mahendar Korthiwada, Priyanka Dixit, Archit Aggarwal |
| Stakeholders Relationship Committee | Sudhir Kumar Bassi (Chairperson), Manoj Kumar Lohariwala, Vinay Lohariwala |
| Risk Management Committee | Vinay Lohariwala (Chairperson), Sudhir Kumar Bassi, Manoj Kumar Lohariwala |
| Corporate Social Responsibility Committee | Vinay Lohariwala (Chairperson), Manoj Kumar Lohariwala, Sudhir Kumar Bassi |
Group Structure of Innova Captab Limited
Innova Captab Limited has 2 subsidiary companies. This group structure data is as of FY 2024. The corporate group structure reflects Innova Captab Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Sharon Bio Medicine Limited | U24110MH1989PLC052251 | - |
| Univentis Medicare Limited | U24232MH2015PLC402722 | - |
Showing major subsidiaries. Total: 2.
Charges & Borrowings of Innova Captab Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2025 | Hdfc Bank Limited | ₹52.32 Cr | Open |
| 29 Sep 2022 | Hdfc Bank Limited | ₹150 Cr | Open |
| 29 Sep 2022 | Hdfc Bank Limited | ₹20 Cr | Open |
| 31 Aug 2017 | Yes Bank Limited | ₹48 Cr | Open |
| 01 Nov 2011 | State Bank of India | ₹235 Cr | Open |
Total charge records: 17 View all charges
Employees and EPFO Compliance at Innova Captab Limited
Innova Captab Limited has a workforce of 1,246 employees as of Jan 09, 2026.
Employee and EPFO history for Innova Captab Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Innova Captab Limited
GST registrations and filing compliance for Innova Captab Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Innova Captab Limited
Credit ratings, litigation, and regulatory alerts for Innova Captab Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Innova Captab Limited
MSME payment history for Innova Captab Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Innova Captab Limited
Corporate group structure for Innova Captab Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Innova Captab Limited
MCA filings and documents for Innova Captab Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Innova Captab Limited
Recent News on Innova Captab Limited
Frequently Asked Questions about Innova Captab Limited
Innova Captab Limited is an active public limited company in the chemicals sector based in Thane, Maharashtra, India. It was incorporated on 03 January 2005 (21+ years old) and is registered under CIN L24246MH2005PLC150371. The company has 1,246 employees.
Innova Captab Limited reported revenue of ₹1,630.02 Cr for FY 2026 (up 31.06% YoY) based on consolidated NSE filings.
The current directors of Innova Captab Limited are:
- Jayant Vasudeo Rao - Whole-Time Director
- Shirish Gundopant Belapure - Director
- Sudhir Kumar Bassi - Director
- Priyanka Dixit - Director
- Archit Aggarwal - Director
- Manoj Kumar Lohariwala - Whole-Time Director
- Vinay Kumar Lohariwala - Managing Director
- Mahendar Korthiwada - Director
The primary industry of Innova Captab Limited is chemicals. The company specifically operates in chemical products. The company is currently active in this sector.
Yes, Innova Captab Limited is a listed company.
Innova Captab Limited can be reached at the registered office: 1513 15Th Floor Satra Plaza Chs Ltd, Plot No. 19 & 20 Sector – 19D Vashi Navi Mumbai, Thane, Maharashtra, India – 400703, or through the website innovacaptab.com.